Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: January 2022

MissionIRNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Announces Strategic Advisory Board Appointment

Posted on January 6, 2022 by MissionIR

Flora (NASDAQ: FLGC), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, today announced the appointment of accomplished business leader and cannabis industry expert Tim Leslie as the chairman of its newly formed advisory board. Establishment of … Continue reading →

Posted in Flora Growth Corp. FLGC | Leave a comment

MissionIRNewsBreaks – Excellon Resources Inc. (TSX: EXN) (NYSE American: EXN) (FRA: E4X2) Releases Update on Company Operations, Explorations

Posted on January 6, 2022 by MissionIR

Excellon Resources (TSX: EXN) (NYSE American: EXN) (FRA: E4X2) has shared an overview of its operations. The update includes information regarding EXN’s Platosa project as well as other upcoming exploration plans; the company stated that additional updates would be forthcoming. The … Continue reading →

Posted in Excellon Resources Inc. EXN | Leave a comment

Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Announces Key Meeting with UK Regulatory Agency

Posted on January 6, 2022 by MissionIR

Meeting takes company a step closer to advancing its lead investigational candidate CYB003 into clinical development CYB003 is designed for the treatment of two significant conditions: major depressive disorder (“MDD”) and alcohol use disorder (“AUD”) CEO notes that CYB003 has … Continue reading →

Posted in Cybin Inc. CYBN | Leave a comment

Lexaria Bioscience Corp. (NASDAQ: LEXX) Increases Investor Visibility with SRAX Inc. (NASDAQ: SRAX)

Posted on January 6, 2022 by MissionIR

The strategic move to incorporate SRAX is designed to bring investor visibility for all of the upcoming events that Lexaria has planned for 2022 Lexaria’s patented DehydraTECH(TM) technology is poised to leverage multiple industries – notably the CBD industry, with … Continue reading →

Posted in Lexaria Bioscience Corp. LEXX | Leave a comment

MissionIRNewsBreaks – PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) Continues ‘Recipe for Success’ to Expand into Additional Market Segments

Posted on January 5, 2022 by MissionIR

PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) recently announced the expansion of its e-commerce platform to the United Kingdom. The new platform, www.PlantX.uk, will offer customers a similar experience as PlantX’s customers in Canada and the United States, … Continue reading →

Posted in PlantX Life Inc. PLTXF | Leave a comment

SRAX Inc. (NASDAQ: SRAX) Set to Benefit as Analysts Hike Company’s Fourth Quarter Revenue Forecasts

Posted on January 5, 2022 by MissionIR

Zacks Investment Research recently raised its forecast for SRAX’s 4Q21 revenues to $10.05mn, representing +122.3% YoY growth Zacks have also upped their fiscal year 2022 revenue forecast to $42.52 million, implying +35% YoY growth SRAX’s implied results look even more … Continue reading →

Posted in SRAX, Inc. SRAX | Leave a comment

Amid Climate Change and National Food Security Concerns, PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) Pursues Status as Plant-based Lifestyle Education Hub

Posted on January 5, 2022 by MissionIR

PlantX Life Inc. is an e-commerce retailer devoted to not only selling plant products, but educating consumers about their effective use and wellness benefits The company has developed a weekly podcast series, YouTube channel videos and an active blog to … Continue reading →

Posted in PlantX Life Inc. PLTXF | Leave a comment

MissionIRNewsBreaks – SRAX Inc. (NASDAQ: SRAX) Releases Dates for 2022 Virtual Conferences

Posted on January 5, 2022 by MissionIR

SRAX (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its SaaS (“SaaS”) platform, has scheduled several industry-specific events for 2022. The company has announced its initial schedule for 2022 conferences. The … Continue reading →

Posted in SRAX, Inc. SRAX | Leave a comment

MissionIRNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Annual Shareholder Letter Provides Company Highlights, 2022 Outlook

Posted on January 5, 2022 by MissionIR

InMed Pharmaceuticals (NASDAQ: INM), a leader in the development, manufacturing and commercialization of rare cannabinoids, has released a shareholder letter. The letter, from president and CEO Eric A. Adams, provided INM shareholders with a company update, including a look at … Continue reading →

Posted in InMed Pharmaceuticals Inc. INM | Leave a comment

MissionIRNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Improving Bioavailability of Pharmaceuticals One Drug Class at a Time

Posted on January 4, 2022 by MissionIR

As a significant number of drugs fail to reach the market owing to poor bioavailability, Lexaria Bioscience Corp. (NASDAQ: LEXX) is among those companies exploring different tools and methods to try to solve the problem. Lexaria is currently leading the … Continue reading →

Posted in Lexaria Bioscience Corp. LEXX | Leave a comment